Founding pharmaceutical network

Move complex biomedical research into a credible, reviewable market conversation.

QAGE² Pharma Growth combines a public research preview with Q-PGA, a human-reviewed agent for evidence-aware positioning, campaign planning, claim-risk screening and institutional-pilot design.

Open free Q-PGA Explore research modules View pricing
Free through 15 July 2026 at 23:59 Singapore time
US$10 once from 16 July 2026
No subscription or automatic renewal. The public research explorer remains free.
⚛

Research-to-market translation

Present exploratory AQDE, AQGRE, BBB/SOKS, oncology, mRNA and quantum-workflow concepts with evidence status and limitations kept visible.

✦

Campaign-agent briefs

Create positioning, permission-led email, social, evidence-workshop and 30-day launch-plan drafts without autonomous sending.

✓

Human-review controls

Flag risky clinical, regulatory, safety, comparative and absolute language before medical, legal, regulatory, privacy and brand review.

Built for organisation-level evaluation

Pharmaceutical R&DTranslational scienceMedical affairsScientific communicationsCommercial strategyMarket accessResponsible AIBiotech BDCRO/CDMO innovationAcademic research
Responsible-use boundary: this is a research and marketing-workflow prototype—not a medical device, diagnostic service or clinical decision-support system. Do not submit patient-identifiable information, protected health information, confidential trial data, private contact databases, credentials or payment-card details. Accountable human review is required before external use.